Jiangsu Medomics Medical Technology Co., Ltd.  

Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10, 000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are LED by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help. At present, Medomics′s series product have been developed according to ISO 13485 Quality system and European CE Certification.

Why Choose Us

Business Type: Manufacturer/Factory & Trading Company
Main Products: In Vitro Diagnostics
Year of Establishment: 2017-10-12
Number of Employees: 156
Cooperated with Fortune 500: No
Repeat Buyers Choice: 80%~100%
Address: 3 / F, Building D, Phase Ii, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjinhu Road, Jiangbei New District, Nanjing, Jiangsu, China
Plant Area: 12871.57 square meters
Registered Capital: 25,519,651 RMB
Main Markets: Southeast Asia/ Mideast, Africa, Australia
Number of Foreign Trading Staff: 6
Supply Chain Partners: 28
Minimum Order Quantity: 1 Set
International Commercial Terms(Incoterms): FOB, CIF, CFR, EXW
Terms of Payment: LC, T/T, D/P, PayPal, Western Union, Small-amount payment
Average Lead Time: Peak Season Lead Time: within 15 workdays
Off Season Lead Time: within 15 workdays
Overseas Agent/Branch: No
Export Year: 7 Years
Nearest Port: Shanghai Port
Production Lines: 1
Inspection Type for Finished Products: Random inspection(Visual inspection & Function inspection)
Inspection Method for Finished Products: Have instructions and uniformly followed
QA/QC Inspectors: 4 people
Traceability of Raw Materials: Yes
ODM Service Available: Yes
OEM Service Available: Yes
R&D Engineers: 42 people
New Products Launched in Last Year: Yes
Customization Options: Customization from Samples, Customization from Designs, Full Customization, Minor Customization, Flexible customization
Production Machines: Auto Processing Line